Tom Duthy
Executive Director / Neurotech International
Most Notable Role
Dr Thomas Duthy has financial market experience in corporate transactions, and held senior executive roles with S&P/ASX Top 100 companies.
Dr Duthy is the founder and chief executive of Nemean Group, an Adelaide-based boutique corporate advisory and investor relations company for the life sciences and technology sectors.
He was formerly the global head of investor relations & corporate development at Sirtex Medical which was sold to CDH Investments in September 2018, and spent ten years as a sell-side healthcare & biotechnology analyst with a focus on small-cap companies.
